GlassScriptPhysician profile
Anne C Moore
NPI 1083113443
$677.57
in general payments reported to CMS, 2019-2025
13 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $158 · 2023: $140 · 2024: $226 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $165.89 | 2022-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $109.45 | 2022-2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $98.61 | 2022-2024 | |
| Novo Nordisk INC | $97.23 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $54.23 | 2024 | Mounjaro, Zepbound |
| Alnylam Pharmaceuticals INC. | $40.85 | 2024 | Onpattro |
| Glaxosmithkline, LLC. | $27.04 | 2022-2025 | Trelegy Ellipta |
| E.R. Squibb & Sons, L.L.C. | $15.41 | 2023 | Eliquis |
| Exact Sciences Corporation | $15.12 | 2025 | The Cologuard Plus Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $13.85 | 2022 | |
| Boston Scientific Corporation | $13.53 | 2025 | Wavewriter Alpha Prime 16 |
| Corium, LLC | $13.21 | 2022 | |
| Pfizer INC. | $13.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.